WoundReference improves clinical decisions
 Choose the role that best describes you
Saracino A, Kelly R, Liew D, Chong A, et al.
The Australasian journal of dermatology. Date of publication 2011 Aug 1;volume 52(3):218-21.
1. Australas J Dermatol. 2011 Aug;52(3):218-21. doi: 10.1111/j.1440-0960.2011.00750.x. Epub 2011 Jul 20. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Saracino A(1), Kelly R, Liew D, Chong A. Author information: (1)Departments of Medicine and Dermatology, St Vincent's Hospital, Melbourne, Victoria, Australia. adnama22@yahoo.com We present a case series of inpatients with pyoderma gangrenosum (PG), an ulcerative neutrophilic skin condition of unknown aetiology. Twenty-six patients were admitted with PG, nine men and 17 women. At the time of the chart review, seven patients (26.9%) had died. Patients had a mean of 2.0 active ulcerative lesions and 22 patients' ulcers (84.6%) were on the lower limb. Systemic diseases were coexistent in 15 patients (57.7%), the most common being rheumatoid arthritis (19.2%). Thirty-eight wound cultures were taken and were positive for Staphylococcus aureus in 22 cases (57.8%) and Pseudomonas aeruginosa in 20 (52.6%). After prednisolone, cyclosporin was the next most commonly prescribed systemic therapy (34.6%). Surgical debridement was undertaken in seven cases (26.9%) and two patients had skin grafts. Upon discharge from hospital, 21 patients' ulcers (80.8%) had improved. At 6 months 50% showed complete ulcer healing. Our results highlight the potential severity of PG requiring hospital admission, the need for aggressive therapy and the overall high associated morbidity and mortality. © 2011 The Authors. Australasian Journal of Dermatology © 2011 The Australasian College of Dermatologists. DOI: 10.1111/j.1440-0960.2011.00750.x PMID: 21834821 [Indexed for MEDLINE]
Appears in following Topics:
Pyoderma Gangrenosum - Treatment